We are international

Myeloma Minute
September 27, 2012

September 27, 2012
Share the Minute Facebook Tweet! Clinical Trials Donate to the IMF

Can’t Make Tonight’s Live Teleconference on Acute and Chronic Pain?

Visit archived version of IMF Teleconference ‘Living Well With Myeloma’

Upcoming Events

Myeloma Center Workshop at UNC/Duke
Chapel Hill, North Carolina
Friday, October 5, 2012

6th Annual Comedy Celebration Tickets on sale now
Saturday, October 27, 2012

Coach Rob's 7th Annual Benefit Bash & Golf Tournament
Orlando, Florida
October 28-29, 2012

Be Bold, Be Bald!
Join the IMF team and wear a bald cap to honor those who battle cancer.
Friday, November 2, 2012

Sacramento Regional Community Workshop
Saturday, November 3, 2012

Myeloma Center Workshop at the Mayo Clinic Scottsdale, Arizona
Saturday, November 17, 2012
IMF President’s Year in Review: Grateful for 12 Months of Incredible Achievement
From the introduction of ‘The Myeloma Post’—the very first myeloma app for the iPad—to the debut of the live-streamed International Myeloma Working Group Conference Series, Susie Novis, President and Co-founder of the IMF, notes the organization’s many achievements in 2012: “The IMF has much to be grateful for as we celebrate our 22nd ‘birthday’ in October and prepare for exciting new goals in the year ahead.” READ MORE

Have Questions About Velcade SQ? We Have the Answers at Our New Resource Page
The IMF Hotline is getting many calls about Velcade SQ. We welcome your calls and encourage everyone interested in learning more to view a new video on the subject at our Velcade Resource page. LEARN MORE

Elotuzumab Clinical Trial Fact Sheet Now Available in 6 Languages
Elotuzumab is a monoclonal antibody that targets CS1, a cell surface glycoprotein highly expressed on myeloma cells but minimally expressed on normal cells. Elotuzumab is currently in clinical trials (called ELOQUENT 1 and ELOQUENT 2) for newly diagnosed, previously untreated and relapsed or refractory myeloma. Click HERE for fact sheets in English, German, French, Italian, Spanish, and Dutch.

If Cookies Are Not Good for You, What Should a Myeloma Patient Eat? x
The relationship of nutrition and myeloma will be examined during the next free IMF teleconference in the ‘Living Well With Myeloma’ series, on Thursday, October 11, at 4PM Pacific / 7PM Eastern. IMF Chairman and Co-founder Brian G.M. Durie, M.D., who has blogged about the latest research on nutrition and myeloma here, will also take questions during the hour-long event. REGISTER HERE

Support Groups Can Help Fund Research to Find a Cure for Myeloma
A new IMF campaign called “Dollars for Research” encourages local myeloma support groups to help fund a grant in their name to a recipient of the prestigious 2013 Brian D. Novis Research Grant Award. To date, the IMF has funded $4.7 million in lab-based research grants. We want to ensure that these promising young researchers continue their important task - to find a cure for myeloma! This year, we are challenging our network of over 115 support groups to raise a total of $50,000 - enough to fund an additional research grant. LEARN HOW TO HELP
Join Our Mailing List  


12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
Privacy Policy | Unsubscribe 

 related articles